Table 3.
Availability of ETAT+ components in Malawi hospitals and lower-level facilities, 2013-2014
| Category | Item | All facilities | Hospitals | Lower-level facilities | |||
|---|---|---|---|---|---|---|---|
| N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | ||
| Total | Total | 977 | 100.0 | 116 | 100.0 | 861 | 100.0 |
| Staff | 24-h staff on call | 389 | 39.8 (36.7–42.9) | 102 | 90.4 (83.4–94.6) | 287 | 33.2 (30.1–36.4) |
| Transport | Ambulance | 322 | 33.0 (30.1–36.0) | 95 | 84.3 (76.5–89.9) | 227 | 26.3 (23.4–29.3) |
| Equipment | Infant scale | 692 | 70.8 (67.8–73.6) | 105 | 92.9 (86.4–96.4) | 587 | 67.9 (64.7–71.0) |
| Child scale | 757 | 77.5 (74.8–80.1) | 98 | 87.0 (79.5–92.0) | 659 | 76.3 (73.3–79.0) | |
| Oxygen source | 239 | 24.4 (21.9–27.2) | 102 | 90.4 (83.4–94.6) | 137 | 15.8 (13.6–18.4) | |
| Suction with catheter/bulb for newborns | 500 | 51.2 (48.0–54.3) | 95 | 84.1 (76.2–89.7) | 405 | 46.9 (43.6–50.2) | |
| Self-inflating bag/mask | 622 | 63.6 (60.5–66.6) | 104 | 92.1 (85.4–95.8) | 518 | 59.9 (56.6–63.2) | |
| Micro nebulizer or spacer for inhalers | 183 | 18.7 (16.4–21.3) | 57 | 50.9 (41.9–60.0) | 125 | 14.5 (12.3–17.0) | |
| Laboratory | Malaria testing | 853 | 87.3 (85.0–89.3) | 109 | 96.5 (91.0–98.7) | 745 | 86.2 (83.6–88.4) |
| Haemoglobin measurement | 202 | 20.6 (18.2–23.3) | 91 | 81.0 (72.8–87.1) | 110 | 12.8 (10.7–15.2) | |
| Blood glucose measurement | 225 | 23.0 (20.5–25.7) | 84 | 74.9 (66.2–82.0) | 140 | 16.2 (13.9–18.9) | |
| Blood typing | 57 | 5.9 (4.5–7.4) | 46 | 40.4 (31.9–49.6) | 11 | 1.3 (0.7–2.3) | |
| Radiology | 69 | 7.1 (5.6–8.8) | 61 | 54.2 (45.1–63.0) | 8 | 0.9 (0.5–1.8) | |
| Medications | Injectable epinephrine / adrenaline | 606 | 62.1 (58.9–65.1) | 91 | 80.9 (72.6–87.1) | 515 | 59.6 (56.3–62.9) |
| Injectable diazepam | 776 | 79.4 (76.7–81.9) | 106 | 93.9 (87.7–97.1) | 670 | 77.5 (74.5–80.2) | |
| Injectable glucose solution | 755 | 77.3 (74.5–79.8) | 103 | 91.3 (84.5–95.3) | 652 | 75.4 (72.4–78.2) | |
| Injectable hydrocortisone | 194 | 19.9 (17.5–22.5) | 55 | 49.2 (40.2–58.2) | 139 | 16.1 (13.7–18.7) | |
| Inhalation salbutamol | 323 | 33.0 (30.1–36.0) | 76 | 67.3 (58.2–75.2) | 247 | 28.5 (25.6–31.7) | |
| Injectable antibiotics | 924 | 94.5 (92.8–95.8) | 111 | 98.2 (93.2–99.6) | 813 | 94.1 (92.2–95.5) | |
| Injectable antimalarials | 859 | 87.9 (85.6–89.8) | 106 | 93.8 (87.6–97.0) | 753 | 87.1 (84.6–89.2) | |
| Fluids | Intravenous fluids | 829 | 84.8 (82.4–87.0) | 109 | 96.4 (90.9–98.7) | 720 | 83.3 (80.6–85.7) |
| Consumables | Syringes with needles | 967 | 98.9 (98.0–99.4) | 112 | 99.1 (93.9–99.9) | 855 | 98.9 (97.9–99.4) |
| Blood transfusion in past 3 months | 73 | 7.4 (6.0–9.2) | 70 | 61.8 (52.6–70.2) | 3 | 0.3 (0.1–1.1) | |
| Cannula for administering IV fluids | 815 | 83.4 (80.9–85.7) | 110 | 97.4 (92.1–99.2) | 706 | 81.6 (78.8–84.1) | |
| Nasogastric tubes | 105 | 10.8 (9.0–12.9) | 39 | 34.5 (26.4–43.6) | 66 | 7.7 (6.1–9.7) | |
Point estimates were weighted to account for unequal probabilities of selection due to facility non-response. There were 1060 facilities included in the Ministry of Health national facility list and 977 (92.1%) facilities were audited as part of this national facility census